Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia
Abstract Negative symptoms are commonly assessed via clinical rating scales; however, these measures have several inherent limitations that impact validity and utility for their use in clinical trials. Objective digital phenotyping measures that overcome some of these limitations are now available....
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-04-01
|
Series: | npj Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-022-00241-z |